In light of the compromised inflammatory processes with AD in microglia, SELENBP1 (Selenium Binding Protein 1) is a very intriguing gene, as failure to maintain sufficient selenium levels adversely affects immune responses and increases cancer risk 48–50. Here, SELENBP1 is linked to cancer.